<DOC>
	<DOCNO>NCT02076503</DOCNO>
	<brief_summary>Prostate cancer frequent cancer Norwegian men . For optimal treatment , accurate stag disease time point diagnosis important . The objective study evaluate diagnostic potential combine PET/MR examination risk assessment detection lymph node metastasis . The overall aim project improve investigator ability provide individually tailor treatment prostate cancer patient . The study include 32 men high-risk prostate cancer , eligible radical prostatectomy . Informed consent requirement inclusion study .</brief_summary>
	<brief_title>Pre-operative PET-MR High Risk Prostate Cancer Patients Assessment Cancer Aggressiveness Lymph Node Status</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>Highrisk prostate cancer accord EAU guideline ( Gleason score ≥8 and/or PSA ≥20 ng/ml and/or ≥ cT3a cancer ) Eligibility surgical procedure ( radical prostatectomy bilateral pelvic lymph node resection ) Previous treatment ( example TURP hormone therapy ) Contraindication PET/MR examination ( include , limited : pacemaker , aneurysm clip , reduce renal function , metal implant , claustrophobia )</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Neoplasm Staging</keyword>
	<keyword>Positron-Emission Tomography</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>1-amino-3-fluorocyclobutane-1-carboxylic acid</keyword>
</DOC>